<DOC>
	<DOCNO>NCT00956319</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety zolpidem modify release ( MR ) tablet use estazolam ( Eurodin ) comparative drug patient primary insomnia .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Zolpidem Modified Release Formulation Insomnia Patients</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Estazolam</mesh_term>
	<criteria>Diagnosis primary insomnia base DSMIV criterion ( 307.42 ) Written informed consent obtain Patients sleep apnea syndrome , narcolepsy , presence suspicion periodic leg movement restless leg syndrome Patients hepatic failure , myasthenia gravis , hypersensitivity zolpidem Patients know current drug alcohol abuser likely concomitantly consume alcoholic beverage ( 3 times/week ) Patients pregnant , lactate intend become pregnant study period Patients receive antidepressant anxiolytic allow change dose discontinue previous medication throughout study Any clinically significant condition , opinion investigator make patient unsuitable trial Participation clinical trial within 1 month prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Zolpidem</keyword>
	<keyword>Estazolam</keyword>
</DOC>